These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 9467629)

  • 21. [Heart failure due to rapid right ventricular volume overload in patients with pulmonary hypertension].
    Sako S; Oka T; Shimoyama M; Kochi T; Yorozu S; Mizuguchi T
    Masui; 1989 Aug; 38(8):1076-82. PubMed ID: 2810704
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prospective evaluation of risk of protamine reactions in patients with NPH insulin-dependent diabetes.
    Levy JH; Zaidan JR; Faraj B
    Anesth Analg; 1986 Jul; 65(7):739-42. PubMed ID: 2424341
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pretreatment with H2 blocker famotidine to ameliorate protamine-induced hypotension in open-heart surgery.
    Mayumi H; Toshima Y; Tokunaga K
    J Cardiovasc Surg (Torino); 1992; 33(6):738-45. PubMed ID: 1287015
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The use of nitric oxide for managing catastrophic pulmonary vasoconstriction arising from protamine administration.
    Ralley FE
    Anesth Analg; 1999 Mar; 88(3):505-7. PubMed ID: 10071995
    [No Abstract]   [Full Text] [Related]  

  • 25. Noncardiogenic pulmonary edema and rhabdomyolsis after protamine administration in a patient with unrecognized McArdle's disease.
    Lobato EB; Janelle GM; Urdaneta F; Malias MA
    Anesthesiology; 1999 Jul; 91(1):303-5. PubMed ID: 10422956
    [No Abstract]   [Full Text] [Related]  

  • 26. Ketanserin in the treatment of protamine-induced pulmonary hypertension.
    van der Starre PJ; Solinas C
    Tex Heart Inst J; 1996; 23(4):301-4. PubMed ID: 8969033
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The importance of aprotinin and pentoxifylline in preventing leukocyte sequestration and lung injury caused by protamine at the end of cardiopulmonary bypass surgery.
    Ege T; Arar C; Canbaz S; Cikirikcioglu M; Sunar H; Yuksel V; Duran E
    Thorac Cardiovasc Surg; 2004 Feb; 52(1):10-5. PubMed ID: 15002070
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hemodynamics of protamine administration. Comparison of right atrial, left atrial, and aortic injections.
    Katz NM; Kim YD; Siegelman R; Ved SA; Ahmed SW; Wallace RB
    J Thorac Cardiovasc Surg; 1987 Dec; 94(6):881-6. PubMed ID: 3682857
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Allergy to protamine.
    Weiss ME; Adkinson NF
    Clin Rev Allergy; 1991; 9(3-4):339-55. PubMed ID: 1782626
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Platelet-activating protamine-heparin-antibodies lead to higher protamine demand in patients undergoing cardiac surgery.
    Grieshaber P; Bakchoul T; Wilhelm J; Wagner A; Wollbrück M; Böning A; Sachs U
    J Thorac Cardiovasc Surg; 2015 Oct; 150(4):967-73.e1. PubMed ID: 26298870
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Anaphylaxis to protamine during cardiovascular surgery].
    Madani H; Sadiki EO; Bouziane M; Amaarouch S; Madani M; Khatouf M
    Ann Pharm Fr; 2014 May; 72(3):143-5. PubMed ID: 24780829
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The heparin-protamine interaction. A review.
    Carr JA; Silverman N
    J Cardiovasc Surg (Torino); 1999 Oct; 40(5):659-66. PubMed ID: 10596998
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The successful management of severe protamine-induced pulmonary hypertension using inhaled prostacyclin.
    Jerath A; Srinivas C; Vegas A; Brister S
    Anesth Analg; 2010 Feb; 110(2):365-9. PubMed ID: 19933533
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A nationwide investigation of a possible protamine drug-product defect.
    Herrera CR; Grasela TH; Walawander CA
    Ann Pharmacother; 1992 May; 26(5):643-4. PubMed ID: 1591423
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [A case of severe coronary artery spasm associated with anaphylactic reaction caused by protamine administration].
    Lee S; Nikai T; Kanata K; Koshizaki M; Nomura T; Saito Y
    Masui; 2005 Sep; 54(9):1043-6. PubMed ID: 16167803
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Protamine reduces whole blood platelet aggregation after cardiopulmonary bypass.
    Olsson A; Alfredsson J; Håkansson E; Svedjeholm R; Berglund J; Berg S
    Scand Cardiovasc J; 2016; 50(1):58-63. PubMed ID: 26402229
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical effects of different protamine doses after cardiopulmonary bypass.
    Svenarud P; Øvrum E
    Asian Cardiovasc Thorac Ann; 2002 Jun; 10(2):119-23. PubMed ID: 12079933
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adverse cardiopulmonary effects and increased plasma thromboxane concentrations following the neutralization of heparin with protamine in awake sheep are infusion rate-dependent.
    Morel DR; Costabella PM; Pittet JF
    Anesthesiology; 1990 Sep; 73(3):415-24. PubMed ID: 2098007
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adverse reactions to protamine sulfate following cardiac surgery.
    Holland CL; Singh AK; McMaster PR; Fang W
    Clin Cardiol; 1984 Mar; 7(3):157-62. PubMed ID: 6705300
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Does an allergy to fish pre-empt an adverse protamine reaction? A case report and a literature review.
    Collins C; O'Donnell A
    Perfusion; 2008 Nov; 23(6):369-72. PubMed ID: 19454566
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.